US Broker Ratings

Glaukos Corporation (GKOS) Stock Analysis: A 23% Upside Potential in the Booming Medical Device Market

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, has been capturing investor attention with its innovative solutions in the medical devices industry. As the company continues to..

Telix Pharmaceuticals Limited (TLX): Analyst Consensus Reveals a Striking 118.65% Potential Upside

Telix Pharmaceuticals Limited (TLX), a leading player in the biopharmaceutical sector, is gaining traction among investors due to its promising pipeline and significant growth potential. Headquartered in North Melbourne, Australia,..

Legend Biotech Corporation (LEGN): Investor Outlook with 60.57% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) stands out in the biopharmaceutical landscape with its impressive growth potential and innovative approach to oncology therapeutics. As a prominent player in the healthcare sector,..

Viatris Inc. (VTRS) Stock Analysis: Navigating Growth Prospects with an 8.09% Potential Upside

Viatris Inc. (VTRS), a prominent player in the healthcare sector, is making waves in the stock market with its recent performance and growth potential. Operating within the Drug Manufacturers –..

Novo Nordisk A/S (NVO) Stock Analysis: Assessing Growth Potential and Dividend Attraction

Novo Nordisk A/S (NVO), a dominant player in the global healthcare sector, continues to make significant strides in the drug manufacturing industry. With a robust market capitalization of $194.35 billion,..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating Growth with a 7.98% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) presents a compelling opportunity for investors keen on the healthcare sector, specifically within biotechnology. With a robust market capitalization of $31.6 billion, Royalty Pharma stands..

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

TransMedics Group, Inc. (TMDX): Investor Outlook on a Medical Device Innovator with a 60.17% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), with a market capitalization of $2.52 billion, stands at the forefront of transforming organ transplant therapy. Known for its pioneering Organ Care System (OCS), the..

Quest Diagnostics Incorporated (DGX) Stock Analysis: A 10% Upside Potential for Investors

For investors seeking opportunities in the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents an intriguing prospect. With a market capitalization of $22.48 billion, Quest Diagnostics is a leading player..

Guardant Health, Inc. (GH) Stock Analysis: Cutting-edge Diagnostics with a 7% Upside Potential

Guardant Health, Inc. (NASDAQ: GH) has emerged as a significant player in the precision oncology space, offering a suite of cutting-edge diagnostic tests that are reshaping cancer detection and research...

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 36.83% Upside in the Thriving Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED) is making waves in the healthcare sector with its innovative solutions for musculoskeletal disorders. With a market capitalization of $10.91 billion, Globus Medical stands as..

Natera, Inc. (NTRA) Stock Analysis: Evaluating a 22.62% Potential Upside in the Diagnostics Arena

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, is gaining attention from the investor community thanks to its impressive revenue..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 26.85% Potential Upside in Health Information Services

For investors keen on opportunities within the healthcare sector, Doximity, Inc. (NYSE: DOCS) presents a compelling case. Headquartered in San Francisco, Doximity operates a thriving digital platform tailored for medical..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a 14.25% Upside Potential in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) stands out in the biotechnology landscape not only for its robust market presence but also for its potential upside of 14.25%. As a key player in..

Charles River Laboratories (CRL) Stock Analysis: Exploring Its 13.20% Potential Upside for Investors

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $9.03 billion,..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Exploring a 17.35% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a titan in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors seeking exposure to precision instruments and services. With..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with Robust Growth Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands tall in the healthcare sector, carving a niche in the specialty and generic drug manufacturing industry. As a leader in diagnostic and therapeutic solutions,..

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking a Potential 114% Upside

ADMA Biologics Inc. (NASDAQ: ADMA) is emerging as a compelling opportunity within the healthcare sector, specifically in the biotechnology industry. With a market capitalization of $1.9 billion, this U.S.-based biopharmaceutical..

RadNet, Inc. (RDNT) Stock Analysis: A 58% Potential Upside Amidst Strong Buy Ratings

In the ever-evolving world of healthcare, RadNet, Inc. (NASDAQ: RDNT) stands out as a formidable player in the diagnostics and research industry. With a market cap of $4.46 billion, this..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds